Correlation of Magnetic Resonance Spectroscopy and Perfusion at Non-Enhancing Edematous Area in High-Grade Glioma for Tumor Recurrence After Maximal Safe Resection
Abstract
Downloads
References
Kleihues P. Pathology and genetics of tumours of the nervous system. In: Cavenee W, editor. In: World Health Organization Classification of Tumours of the Nervous System, Editorial and Consensus Conference Working Group. Lyon, France: IARC Press; 2000.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109. Epub 2007/07/10.
Scheithauer BW, Fuller GN, VandenBerg SR. The 2007 WHO classification of tumors of the nervous system: controversies in surgical neuropathology. Brain Pathol. 2008;18(3):307-16. Epub 2008/06/06.
Wen PY, Kesari S. Malignant gliomas. Curr Neurol Neurosci Rep. 2004;4(3):218-27. Epub 2004/ 04/23.
DeAngelis LM. Brain tumors. N Engl J Med. 2001;344(2):114-23. Epub 2001/01/11.
Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, et al. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. Int J Radiat Oncol Biol Phys. 2006;64(3):892-7. Epub 2006/02/07.
Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492-507. Epub 2008/ 08/02.
Wild-Bode C, Weller M, Wick W. Molecular determinants of glioma cell migration and invasion. J Neurosurg. 2001;94(6):978-84. Epub 2001/06/21.
Croteau D, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rock JP, et al. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery. 2001;49(4):823-9. Epub 2001/ 09/21.
Kelly PJ, Daumas-Duport C, Kispert DB, Kall BA, Scheithauer BW, Illig JJ. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg. 1987;66(6):865-74. Epub 1987/06/01.
Silbergeld DL, Chicoine MR. Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg. 1997;86(3): 525-31. Epub 1997/03/01.
Dowling C, Bollen AW, Noworolski SM, McDermott MW, Barbaro NM, Day MR, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol. 2001;22(4):604-12. Epub 2001/04/06.
Chan AA, Lau A, Pirzkall A, Chang SM, Verhey LJ, Larson D, et al. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma. J Neurosurg. 2004;101(3):467-75. Epub 2004/ 09/09.
Costanzo A, Scarabino T, Trojsi F, Popolizio T, Catapano D, Giannatempo GM, et al. Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent. European Radiology. 2008;18(8):1727-35.
Wald LL, Nelson SJ, Day MR, Noworolski SE, Henry RG, Huhn SL, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg. 1997;87(4):525-34. Epub 1997/10/10.
Ross BD, Colletti P, Lin AP. MR spectroscopy of the brain: Neurospectroscopy. In: Edelman RR, Hesselink JR, Zlatkin MB, III JVC, editors. Clinical Magnetic Resonance Imaging. 3 ed. Philadelphia: Saunders-Elsevier; 2006. p. 1840-910.
Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol. 1996;17(1):1-15. Epub 1996/01/01.
Ramin SL, Tognola WA, Spotti AR. Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions. Sao Paulo Med J. 2003;121(6):254-9. Epub 2004/03/03.
ชวาลภาฤทธิ์ อ. เอ็มอาร์ไอทางคลินิกของโรคระบบประสาทที่พบบ่อย. กรุงเทพ: โรงพิมพ์เรือนแก้วการพิมพ์; 2552.
Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008; 62(4):753-64; discussion 264-6. Epub 2008/ 05/23.
McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110(1): 156-62. Epub 2008/10/14.
Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys. 1993;26(2):239-44. Epub 1993/05/20.
Proescholdt MA, Macher C, Woertgen C, Brawanski A. Level of evidence in the literature concerning brain tumor resection. Clin Neurol Neurosurg. 2005; 107(2):95-8. Epub 2005/02/15.
Hou LC, Veeravagu A, Hsu AR, Tse VC. Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg focus. 2006; 20(4):E5.
Weybright P. Differentiation Between Brain Tumor Recurrence and Radiation Injury Using MR Spectroscopy. American Journal of Roentgenology. 2005; 185(6):1471-6.
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-66. Epub 2009/03/10.
McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg. 2009;110(3):583-8. Epub 2008/12/03.
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-8. Epub 2002/01/10.
Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, et al. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 2008;15(10):2887-93. Epub 2008/07/19.
T Sugahara, Y Korogi, M Kochi, I Ikushima, T Hirai, T Okuda, Y Shigematsu, L Liang, Y Ge, Y Ushio and M Takahashi Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. American Journal of Roentgenology December 1998, Volume 171, Number 6
Stephan G. Wetzel, Dr med2,, Soonmee Cha, MD,, Glyn Johnson, PhD,, Peter Lee, BS,, Meng Law, MD,, David L. Kasow, MD,, Sean D. Pierce, MD, and, Xiaonan Xue, PhD Relative Cerebral Blood Volume Measurements in Intracranial Mass Lesions: Interobserver and Intraobserver Reproducibility Study See comment in PubMed Commons belowRadiology. 2002 Sep;224(3):797-803
Suban, CORRELATION OF MAGNETIC RESONANCE SPECTROSCOPY AT NON-ENHANCING EDEMATOUS AREA IN HIGH-GRADE GLIOMA FOR TUMOR RECURRENCE AFTER MAXIMAL SAFE RESECTION
Saurabh Sinhaa, Mark E. Bastinb, Ian R. Whittlea and Joanna M. Wardlawa Diffusion Tensor MR Imaging of High-Grade Cerebral Gliomas
Chen-Xing Wu1, Guo-Shi Lin2, Zhi-Xiong Lin*, JianDong Zhan, Shui-Yuan Liu2and Chang-Fu Zho Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles in this journal are copyrighted by the x may be read and used for academic purposes, such as teaching, research, or citation, with proper credit given to the author and the journal.use or modification of the articles is prohibited without permission.
statements expressed in the articles are solely the opinions of the authors.
authors are fully responsible for the content and accuracy of their articles.
other reuse or republication requires permission from the journal."